SFI
AGTC

Susquehanna Fundamental Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$103K Hold
96,020
– – ﹤0.01% 1448
2021
Q4 		$182K Buy
96,020
+13,170
+16% +$31.6K ﹤0.01% 1271
2021
Q3 		$249K Buy
+82,850
New +$295K ﹤0.01% 1465
2020
Q4 		– Sell
-23,300
Closed -$113K – 1656
2020
Q3 		$113K Buy
+23,300
New +$127K ﹤0.01% 1271

Other funds holding AGTC

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Susquehanna Fundamental Investments's AGTC Position: Q1 2022 in Review

Susquehanna Fundamental Investments held its Applied Genetic Technologies Corporation (AGTC) position steady in Q1 2022 at 96,020 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Susquehanna Fundamental Investments first reported a position in AGTC in Q3 2020 and has held it in 4 quarters since. The position peaked at $249K in Q3 2021. 53 funds tracked by Wall St. Rank hold AGTC as of Q1 2022.

  • Susquehanna Fundamental Investments held 96,020 shares of Applied Genetic Technologies Corporation worth $103K as of Q1 2022.
  • Susquehanna Fundamental Investments left its Applied Genetic Technologies Corporation share count unchanged in Q1 2022.
  • Applied Genetic Technologies Corporation made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1448 holding.
  • Susquehanna Fundamental Investments first reported a position in Applied Genetic Technologies Corporation in Q3 2020 and has held it in 4 quarters since.
  • Susquehanna Fundamental Investments's Applied Genetic Technologies Corporation position peaked at $249K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.